These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 34654619)

  • 1. Natural history of children and adults with phenylketonuria in the NBS-PKU Connect registry.
    Kenneson A; Singh RH
    Mol Genet Metab; 2021 Nov; 134(3):243-249. PubMed ID: 34654619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of comorbid conditions among adult patients diagnosed with phenylketonuria.
    Burton BK; Jones KB; Cederbaum S; Rohr F; Waisbren S; Irwin DE; Kim G; Lilienstein J; Alvarez I; Jurecki E; Levy H
    Mol Genet Metab; 2018 Nov; 125(3):228-234. PubMed ID: 30266197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018: Is It a Changing Landscape?
    Pinto A; Ahring K; Almeida MF; Ashmore C; Bélanger-Quintana A; Burlina A; Coşkun T; Daly A; van Dam E; Dursun A; Evans S; Feillet F; Giżewska M; Gökmen-Özel H; Hickson M; Hoekstra Y; Ilgaz F; Jackson R; Leśniak A; Loro C; Malicka K; Patalan M; Rocha JC; Sivri S; Rodenburg I; van Spronsen F; Strączek K; Tokatli A; MacDonald A
    Nutrients; 2024 Jun; 16(13):. PubMed ID: 38999811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of newborn screening connect (NBS connect): a self-reported patient registry and its role in improvement of care for patients with inherited metabolic disorders.
    Osara Y; Coakley K; Devarajan A; Singh RH
    Orphanet J Rare Dis; 2017 Jul; 12(1):132. PubMed ID: 28724394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unmet needs in PKU and the disease impact on the day-to-day lives in Brazil: Results from a survey with 228 patients and their caregivers.
    Martins AM; Pessoa ALS; Quesada AA; Ribeiro EM
    Mol Genet Metab Rep; 2020 Sep; 24():100624. PubMed ID: 32742934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The challenges of managing coexistent disorders with phenylketonuria: 30 cases.
    MacDonald A; Ahring K; Almeida MF; Belanger-Quintana A; Blau N; Burlina A; Cleary M; Coskum T; Dokoupil K; Evans S; Feillet F; Giżewska M; Gokmen Ozel H; Lotz-Havla AS; Kamieńska E; Maillot F; Lammardo AM; Muntau AC; Puchwein-Schwepcke A; Robert M; Rocha JC; Santra S; Skeath R; Strączek K; Trefz FK; van Dam E; van Rijn M; van Spronsen F; Vijay S
    Mol Genet Metab; 2015 Dec; 116(4):242-51. PubMed ID: 26498184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.
    Levy H; Lamppu D; Anastosoaie V; Baker JL; DiBona K; Hawthorne S; Lindenberger J; Kinch D; Seymour A; McIlduff M; Watling S; Vockley J
    Mol Genet Metab; 2020 Mar; 129(3):177-185. PubMed ID: 31883647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results.
    Giżewska M; MacDonald A; Bélanger-Quintana A; Burlina A; Cleary M; Coşkun T; Feillet F; Muntau AC; Trefz FK; van Spronsen FJ; Blau N
    Eur J Pediatr; 2016 Feb; 175(2):261-72. PubMed ID: 26350228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to clinic recommendations among patients with phenylketonuria in the United States.
    Jurecki ER; Cederbaum S; Kopesky J; Perry K; Rohr F; Sanchez-Valle A; Viau KS; Sheinin MY; Cohen-Pfeffer JL
    Mol Genet Metab; 2017 Mar; 120(3):190-197. PubMed ID: 28162992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating change in diet with pegvaliase treatment in adults with phenylketonuria: Analysis of phase 3 clinical trial data.
    Rohr F; Burton B; Dee A; Harding CO; Lilienstein J; Lindstrom K; MacLeod E; Rose S; Singh R; van Calcar S; Whitehall K
    Mol Genet Metab; 2024 Mar; 141(3):108122. PubMed ID: 38184920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to tetrahydrobiopterin therapy in patients with phenylketonuria.
    Rohr F; Wessel A; Brown M; Charette K; Levy HL
    Mol Genet Metab; 2015 Jan; 114(1):25-8. PubMed ID: 25467057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction of sapropterin dihydrochloride as standard of care in patients with phenylketonuria.
    Vernon HJ; Koerner CB; Johnson MR; Bergner A; Hamosh A
    Mol Genet Metab; 2010 Jul; 100(3):229-33. PubMed ID: 20418136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of phenylketonuria in Thailand.
    Kietduriyakul V; Komkris V; Tongkittikul K; Leangphibul P
    J Med Assoc Thai; 1989 Sep; 72(9):516-9. PubMed ID: 2809457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study.
    Keil S; Anjema K; van Spronsen FJ; Lambruschini N; Burlina A; Bélanger-Quintana A; Couce ML; Feillet F; Cerone R; Lotz-Havla AS; Muntau AC; Bosch AM; Meli CA; Billette de Villemeur T; Kern I; Riva E; Giovannini M; Damaj L; Leuzzi V; Blau N
    Pediatrics; 2013 Jun; 131(6):e1881-8. PubMed ID: 23690520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "MY PKU": increasing self-management in patients with phenylketonuria. A randomized controlled trial.
    Ten Hoedt AE; Hollak CE; Boelen CC; van der Herberg-van de Wetering NA; Ter Horst NM; Jonkers CF; Wijburg FA; Bosch AM
    Orphanet J Rare Dis; 2011 Jun; 6():48. PubMed ID: 21708003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, placebo-controlled, double-blind study of sapropterin to treat ADHD symptoms and executive function impairment in children and adults with sapropterin-responsive phenylketonuria.
    Burton B; Grant M; Feigenbaum A; Singh R; Hendren R; Siriwardena K; Phillips J; Sanchez-Valle A; Waisbren S; Gillis J; Prasad S; Merilainen M; Lang W; Zhang C; Yu S; Stahl S
    Mol Genet Metab; 2015 Mar; 114(3):415-24. PubMed ID: 25533024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial.
    Trepp R; Muri R; Abgottspon S; Bosanska L; Hochuli M; Slotboom J; Rummel C; Kreis R; Everts R
    Trials; 2020 Feb; 21(1):178. PubMed ID: 32054509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic literature review of the somatic comorbidities experienced by adults with phenylketonuria.
    Whitehall KB; Rose S; Clague GE; Ahring KK; Bilder DA; Harding CO; Hermida Á; Inwood A; Longo N; Maillot F; Muntau AC; Pessoa ALS; Rocha JC; Rohr F; Sivri S; Said J; Oshinbolu S; Sibbring GC
    Orphanet J Rare Dis; 2024 Aug; 19(1):293. PubMed ID: 39135125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of sapropterin before and during pregnancy: Final analysis of the Kuvan® Adult Maternal Paediatric European Registry (KAMPER) maternal and Phenylketonuria Developmental Outcomes and Safety (PKUDOS) PKU-MOMs sub-registries.
    Feillet F; Ficicioglu C; Lagler FB; Longo N; Muntau AC; Burlina A; Trefz FK; van Spronsen FJ; Arnoux JB; Lindstrom K; Lilienstein J; Clague GE; Rowell R; Burton BK;
    J Inherit Metab Dis; 2024 Jul; 47(4):636-650. PubMed ID: 38433424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of phenylketonuria in adult patients in Italy: a survey of six specialist metabolic centers.
    Burlina A; Leuzzi V; Spada M; Carbone MT; Paci S; Tummolo A
    Curr Med Res Opin; 2021 Mar; 37(3):411-421. PubMed ID: 33222540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.